Innovative biotech stocks have a good chance of breaking out in 2025
The trends may be turning in favor of biotech stocks in 2025 after several years of poor performance, but it…
Gilead Sciences Inc.
Gilead's lenacapavir reduced HIV infections by 96% in trial
A pharmacist holds a bottle of lenacapavir, the new injectable drug for HIV prevention. Nardus Engelbrecht | AP GileadPfizer's twice-yearly…
Gilead denounces drug counterfeiting operation in New York pharmacies
Bottles of Gilead HIV prescriptions seized at Best Scripts pharmacy Courtesy: Gilead Sciences Gilead Sciences says it uncovered a dangerous…
Paradromics launches registry of patients with brain implants
Do you think a friend or colleague should receive this newsletter? this link with them to register. Aamir Ahmed Khan,…
Eli Lilly and drug makers show data on weight loss drugs
An injectable pen of Zepbound, Eli Lilly's weight loss drug, is on display in New York City on December 11,…
Gilead PrEP lenacapavir succeeds in phase 3 trial
The logo of the pharmaceutical company Gilead Sciences in Oceanside, California, on April 29, 2020. Mike Blake | Reuters GileadThe…
Gilead Shares Fall After Disappointing Lung Cancer Study Results
soup images | Light rocket | fake images Actions of Gilead fell more than 9% on Monday after a key…